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background:  Drug eluting stents (DES) are reported to significantly decrease intermediate term target lesion revascularization (TLR) 
rates compared to bare metal stents (BMS). This DES advantage is, however, tempered by essentially equivalent hard clinical results, and 
evidence of a late DES TLR “catch-up” phenomenon.
methods:  We analyzed native coronary TLR from a single institution PCI data [1998-2010: 12,647 patients; 17,318 PCI]. TLR was defined 
as repeat revascularization of a previously stented coronary segment. Hazard ratios (95% confidence interval) comparing BMS to first and 
second (DES-1/2) generation DES were derived by Cox regression with comprehensive risk adjustment (27 covariates).
results:  Compared to BMS (n = 9,895), DES-1 (n = 8,622) treated lesions showed lower early TLR rates (1-yr: 2.2% vs. 3.3%) but higher 
per year TLR (catch-up) rates between 1 and 8 years (0.6%/yr vs 0.4%/yr). [Fig] After adjustment, DES-1 was associated with superior 
intermediate [HR (3-yr) = 0.69 (0.56-0.84)] and late [HR (8-yr) = 0.74 (0.62-0.89)] TLR. Alternatively, DES-2 (n = 4,455) showed significantly 
lower 3-yr TLR rates compared to both BMS [HR (3-yr) = 0.42 (0.31-0.57)] and DES-1 [HR (3-yr) = 0.76 (0.57-1.01)] treated lesions.
Conclusion:  Despite clear evidence of a late catch-up phenomenon, risk adjusted 8-year TLR rates are favorable for DES compared to 
BMS. Importantly, the notable reduction in TLR rates with second generation DES mitigates late catch-up concerns observed with first 
generation DES.
 
